Latest news for Propanc Biopharma (OTC:PPCB) Stock

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

PROPANC BIOPHARMA INC by Propanc Biopharma, Inc.

Propanc Biopharma Inc

HC Wainwright &amp; Co. analyst Scott Buck reiterates Transcat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) with a Buy and maintains $156 price target.

News

Price Target

Reiteration

Analyst Ratings

TRNS

HC Wainwright & Co. Reiterates Buy on Transcat, Maintains $156 Price Target

Earnings

Earnings Beats

ZBRA

Zebra Technologies Q2 2024 Adj. EPS $3.18 Beats $2.81 Estimate, Sales $1.217B Beat $1.182B Estimate

The Democratic party&#8217;s campaign against Republican Donald Trump has gained momentum with Vice President Kamala Harris&#8217; addition to the ticket. However, a few key lawmakers are yet to extend their endorsement.
What Happened: Out of the 35 competitive races that will determine the control of the U.S. House of Representatives in the upcoming November 5 election, 12 Democratic incumbents or challengers have not endorsed Harris, Reuters reported on Tuesday. These lawmakers are positioning themselves as independent decision-makers who prioritize their constituents over national politics.
Maine Representative Jared Golden (D-Maine) one of the 12, plans to evaluate Harris&#8217; proposed policies before deciding whether to support her.
He stated, &#8220;Our choice in leaders should never be a knee-jerk decision driven solely by party loyalty.&#8221; 
Golden is among six House Democrats who voted in favor of a Republican resolution condemning the Biden administration&#8217;s handling of migrants at the Mexico border. These Democrats are from Alaska, Colorado, Maine, North Carolina, Texas, and Washington state.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40001633/scaramucci-i-agree-with-every-single-thing-trump-has-said-on-bitcoin?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Scaramucci: &#8216;I Agree With Every Single Thing&#8217; Trump Has Said On Bitcoin</a>
Despite some hesitation, the wider Democratic Party has quickly rallied behind Harris since Biden endorsed her on July 21. Harris&#8217; campaign reported over $200 million in donations and 170,000 volunteers in the first week. Opinion polls show her closing the gap on Trump, reshaping the race and potentially boosting down-ballot candidates.
However, the need for support from the House is crucial. If Democrats win control of the House, they could either help drive Harris&#8217; agenda forward if she wins or serve as a bulwark against Trump if he prevails.
Why It Matters: A recent WSJ poll indicated that while <a href="https://www.benzinga.com/news/24/07/39996908/trump-vs-harris-new-poll-shows-ex-president-leading-democratic-candidate-by-a-narrow-margin-but-vice">Trump is leading </a>Harris by a narrow margin, the incumbent VP is faring much better than President Joe Biden who stepped out of the presidential race.
Harris&#8217; infectious laughter has <a href="https://www.benzinga.com/markets/cannabis/24/07/40001997/kamala-harriss-hearty-laugh-why-does-it-bother-donald-trump-and-his-followers-so-much">become a point of contention</a> in political circles since she assumed office as Biden&#8217;s VP in January 2021. Critics, led by Trump, have exploited her laughter, calling it a liability and using it to undermine her.
On the other hand, Harris&#8217; campaign has seen a <a href="https://www.benzinga.com/news/24/07/40002603/kamala-harris-raises-200m-in-a-week-66-of-that-money-is-from-donors-reveals-campaign-manager-a-peopl">significant boost since Biden&#8217;s </a>endorsement, raising $200 million and adding 170,000 new volunteers in a week. 66% of this funding came from new donors, indicating a strong people-powered campaign.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40003111/potential-kamala-harris-vp-pick-pete-buttigieg-says-voters-are-worried-about-age-and-acuity-of-presi?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Potential Kamala Harris VP Pick Pete Buttigieg Says &#8216;Voters Are Worried About Age And Acuity Of President Trump&#8217;</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

General

As Kamala Harris Gains Momentum Against Trump, Not Every Democratic Lawmaker Is By Her Side Yet

As previously disclosed, on May 7, 2024, Alaska and Hawaiian certified substantial compliance with a request for additional information and documentary material (the &ldquo;Second Request&rdquo;) received from the Antitrust Division of the Department of Justice (the &ldquo;DOJ&rdquo;) on February 7, 2024 in connection with the DOJ&rsquo;s review of the Merger, which triggered the start of a Review Period (as defined below) under a timing agreement Alaska and Hawaiian entered into with the DOJ on March 27, 2024.
Pursuant to the timing agreement, Alaska and Hawaiian agreed, among other things, not to consummate the Merger before 90 days following the date on which both parties certified substantial compliance with the Second Request (the &ldquo;Review Period&rdquo;) unless they received written notice from the DOJ prior to the end of the Review Period that the DOJ has closed its investigation of the Merger. The Review Period was previously scheduled to expire on August 5, 2024.

On July 29, 2024, Alaska And Hawaiian Agreed With DoJ To Extend Review Period Until 12:01 A. M. Eastern Time On August 15, 2024 - Filing

Needham analyst Mike Matson reiterates Hologic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) with a Buy and maintains $90 price target.

HOLX

Needham Reiterates Buy on Hologic, Maintains $90 Price Target

Tech

INFY

Infosys Partners With Danish Digital Infrastructure Provider, TDC Net To Boost Digital Transformation

&quot;As we execute on our strategy to return to profitability, we remain focused on delivering on our near-term financial goals. In the second half, we expect sequential year-over-year unit revenue momentum to bolster the top-line, supported by our&nbsp;$300 million&nbsp;of revenue initiatives and the continuing normalization of competitive capacity in our core geographies,&quot; said Marty St. George.
&quot;We&#39;ve faced a number of unit cost headwinds this year, including approximately one point of pressure from the change in recognition of Pratt &amp; Whitney compensation and one point from lower capacity than planned, yet we are maintaining our full year CASM-ex Fuel(1)&nbsp;guidance&nbsp;and now expect it be in the range of&nbsp;6.5%&nbsp;-&nbsp;8.5%&nbsp;for the full year,&quot; said Ursula Hurley.&nbsp;

Guidance

JBLU

JetBlue Expects Q3 Revenue To Decline (5.5%) - (1.5%) Y/Y; Now Sees FY24 Revenue To Decline (6.0%) - (4.0%) Vs Prior Forecast Of Down Low Single Digits

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.14 per share. This is a 180 percent increase over earnings of $0.05 per share from the same period last year. The company reported $2.92 billion in sales this quarter. This is a 14.67 percent increase over sales of $2.54 billion the same period last year.

Nomura Holdings Q1 EPS $0.14 Up From $0.05 YoY, Sales $2.92B Up From $2.54B YoY

SK Capital Partners Acquires North America Composites & Fuel Containment Division With $350M In Annual Sales From Parker Hannifin

Microsoft Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has reportedly been issuing a warning to millions of Windows 11 users about the significance of data backup.
What Happened: Microsoft has been displaying a full-screen pop-up message to its users, highlighting the need&nbsp;to back up their files&nbsp;using its cloud storage service, OneDrive, reported&nbsp;<a href="https://www.forbes.com/sites/zakdoffman/2024/07/29/microsoft-windows-11-new-update-warning-hits-millions-of-desktops/">Forbes</a>, citing Windows Latest.
The full-screen popup promotes Windows 11&#8217;s feature to &#8220;backup your desktop, documents and pictures folder in the cloud so you have peace of mind knowing they're protected, even if something happens to this PC.&#8221;
However, the free storage limit on OneDrive is capped at 5GB. Depending on the amount of data included in the backup, which may vary between users, some might need to pay for additional storage.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/07/39997764/elon-musk-bernard-arnault-once-discussed-potential-spacex-louis-vuitton-collab-im-afraid-he-will-ask?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk, Bernard Arnault Once Discussed Potential SpaceX-Louis Vuitton Collab: &#8216;I&#8217;m Afraid He Will Ask Me To Go With Him In The Rocket&#8217;</a>
This move is seen as Microsoft capitalizing on its dominant position in the desktop OS market to push its other products and services. This new OneDrive campaign follows a series of similar initiatives for its browser, Edge, the report noted.
While data backup is indeed essential, users are advised to carefully evaluate which service to use. Despite OneDrive&#8217;s seamless integration with Windows, changing and transferring files can be a complex process once committed.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: This warning comes in the <a href="https://www.benzinga.com/news/24/07/39875506/crowdstrikes-faulty-microsoft-windows-update-gets-slammed-by-us-cybersecurity-official-was-a-huge-de">wake of a&nbsp;faulty update</a>&nbsp;from CrowdStrike earlier this month that led to a global IT outage. 
It was criticized by a leading U.S. cybersecurity official who said that while the outage &#8220;wasn&#8217;t malicious, it was a serious mistake.&#8221;
Microsoft&#8217;s inability to secure Windows like Apple Inc. secures MacOS due to a prior agreement with the European Commission has also been a point of contention. 
Following the CrowdStrike incident, Microsoft&nbsp;stated&nbsp;that it is legally <a href="https://www.benzinga.com/news/24/07/39877477/microsoft-blames-european-commission-agreement-as-reason-it-cant-secure-windows-like-apple-secures-m">unable to adopt the same security</a> measures as Apple due to this agreement.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40027527/mark-zuckerberg-gets-triggered-by-closed-ai-models-at-siggraph-2024-drops-f-bomb-while-talking-with?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Gets Triggered By Closed AI Models At SIGGRAPH 2024, Drops F-Bomb While Talking With Nvidia CEO Jensen Huang: &#8216;There Goes Our Broadcast Opportunity&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Media

MSFT

Microsoft's Windows Reportedly Warns Users To Backup Their Data In The Cloud To Have 'Peace Of Mind' — But At What Price?

B of A Securities analyst Jason Kupferberg upgrades Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Neutral to Buy and maintains the price target from $36 to $36.

Upgrades

AFRM

B of A Securities Upgrades Affirm Holdings to Buy, Maintains Price Target to $36

Needham analyst Mike Cikos reiterates Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and maintains $38 price target.

CFLT

Needham Reiterates Buy on Confluent, Maintains $38 Price Target

Philip Morris Signs An MoU With South Korean Tobacco Products Maker, KT&G On U.S. Regulatory Submissions For The Latter's Products

The SavvyWire guidewire is the world&#39;s first and only sensor-guided 3-in-1 solution for Transcatheter Aortic Valve Implantation

Health Care

Haemonetics Announced CE Mark Certification And The First Commercial European Procedures For SavvyWire Pre-Shaped Pressure Guidewire

JetBlue Says Announcing Incremental Aircraft Deferral Of ~$3B Of Planned Capital Expenditures

Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.58 by 5.17 percent. The company reported quarterly sales of $755.000 million which beat the analyst consensus estimate of $715.710 million by 5.49 percent. This is a 19.09 percent increase over sales of $634.000 million the same period last year.

ARCC

Ares Capital Q2 2024 Adj. EPS $0.61 Beats $0.58 Estimate, Sales $755.000M Beat $715.710M Estimate

Needham analyst Alex Henderson maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and lowers the price target from $425 to $375.

CRWD

Needham Maintains Buy on CrowdStrike Holdings, Lowers Price Target to $375

JetBlue Says Poised To Generate $800M - $900M Of Incremental EBIT From 2025 Through 2027 And Expects The Benefit To Be Realized Evenly Over Those Three Years

CRVL

CorVel Q1 2025 EPS $1.25 Up From $1.14 YoY, Sales $211.72M Up From $190.25M YoY

Nautilus Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAUT#NASDAQ">NAUT</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 7.69 percent decrease over losses of $(0.13) per share from the same period last year.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Propanc Biopharma

News

Latest news for Propanc Biopharma (OTC:PPCB) Stock

Tuesday, March 24, 2020